Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity have?
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity has 293 citations in the OpenAlex counts ScholarIQ stores.
When was Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity published?
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity has 2004 year in the ScholarIQ index.
What is the open-access status of Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity?
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity has closed oa status in the ScholarIQ index.
What is the DOI of Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity?
The DOI for Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity is on the source record.
What is the PMID of Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity?
The PMID for Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity is on the source record.
What is the OpenAlex record for Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity?
The OpenAlex for Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity is on the source record.